These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 25768715)

  • 21. Thyroid neoplasia.
    Curran PG; DeGroot LJ
    Curr Ther Endocrinol Metab; 1994; 5():108-12. PubMed ID: 7704691
    [No Abstract]   [Full Text] [Related]  

  • 22. Radioiodine-resistant differentiated thyroid cancer: hope for the future.
    Hodak SP; Carty SE
    Oncology (Williston Park); 2009 Aug; 23(9):775-6. PubMed ID: 19777763
    [No Abstract]   [Full Text] [Related]  

  • 23. [The external radiotherapy of differentiated thyroid carcinoma].
    Sautter-Bihl ML; Heinze HG
    Dtsch Med Wochenschr; 1992 Apr; 117(17):665-8. PubMed ID: 1369745
    [No Abstract]   [Full Text] [Related]  

  • 24. The use of radioactive iodine in patients with papillary and follicular thyroid cancer.
    Wartofsky L; Sherman SI; Gopal J; Schlumberger M; Hay ID
    J Clin Endocrinol Metab; 1998 Dec; 83(12):4195-203. PubMed ID: 9851751
    [No Abstract]   [Full Text] [Related]  

  • 25. Update on thyroid cancer treatment.
    Regalbuto C; Frasca F; Pellegriti G; Malandrino P; Marturano I; Di Carlo I; Pezzino V
    Future Oncol; 2012 Oct; 8(10):1331-48. PubMed ID: 23130931
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Update on recent developments in the therapy of differentiated thyroid cancer.
    Middendorp M; Grünwald F
    Semin Nucl Med; 2010 Mar; 40(2):145-52. PubMed ID: 20113682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adjuvant treatment of thyroid cancer.
    Beauduin M; Hermans J; Majois F
    Acta Otorhinolaryngol Belg; 1987; 41(5):944-5. PubMed ID: 3454107
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of metastatic thyroid cancer.
    Leeper RD; Shimaoka K
    Clin Endocrinol Metab; 1980 Jul; 9(2):383-404. PubMed ID: 6994947
    [No Abstract]   [Full Text] [Related]  

  • 29. Nonsurgical treatment of thyroid tumours and its results.
    Scott JS
    Proc R Soc Med; 1974 Nov; 67(11):1106-7. PubMed ID: 4438292
    [No Abstract]   [Full Text] [Related]  

  • 30. Novel Therapeutics in Radioactive Iodine-Resistant Thyroid Cancer.
    Fullmer T; Cabanillas ME; Zafereo M
    Front Endocrinol (Lausanne); 2021; 12():720723. PubMed ID: 34335481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The medullary (C-cell) carcinoma of the thyroid. A therapeutic dilemma].
    Schumann J; Hauk H; Leonhardi B
    Chirurg; 1977 Oct; 48(10):666-70. PubMed ID: 913180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Iodine-131 therapy of thyroid cancer: extensive contamination of the hospital room in a patient with tracheostomy.
    Kappes RS; Sarkar SD; Har-El G; Strashun AM; Dunn EK; Schussler GC
    J Nucl Med; 1994 Dec; 35(12):2053-4. PubMed ID: 7989991
    [No Abstract]   [Full Text] [Related]  

  • 33. [Radioiodine treatment of differentiated thyroid carcinomas: residual ablation].
    Konrády A
    Orv Hetil; 2002 Jun; 143(25):1557; author reply. PubMed ID: 12577410
    [No Abstract]   [Full Text] [Related]  

  • 34. Proceedings: Management of cancer of the thyroid: a summary.
    Strong EW
    Proc Natl Cancer Conf; 1972; 7():179-85. PubMed ID: 4587645
    [No Abstract]   [Full Text] [Related]  

  • 35. [Radioiodine and thyroid carcinoma].
    Valdés M; Pineda G
    Rev Med Chil; 1977 Sep; 105(9):603-8. PubMed ID: 757828
    [No Abstract]   [Full Text] [Related]  

  • 36. Radioiodine therapy for thyroid cancer in the era of risk stratification and alternative targeted therapies.
    Pryma DA; Mandel SJ
    J Nucl Med; 2014 Sep; 55(9):1485-91. PubMed ID: 25134528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mitogen-Activated Protein Kinase Inhibitor Selumetinib Fails to Increase the Complete Response Rate of Radioactive Iodine Alone in High-Risk Differentiated Thyroid Cancer: Lessons From the Phase III ASTRA Study.
    Brose MS; Pryma DA; Newbold KL
    J Clin Oncol; 2022 Jun; 40(17):1847-1849. PubMed ID: 35486879
    [No Abstract]   [Full Text] [Related]  

  • 38. Long-term recurrence of thyroid cancer after thyroid remnant ablation with 1.1 and 3.7 GBq radioiodine.
    Rosário PW; Purisch S; Vasconcelos FP; Padrão EL; Rezende LL; Barroso AL
    Nucl Med Commun; 2007 Jun; 28(6):507-8. PubMed ID: 17460543
    [No Abstract]   [Full Text] [Related]  

  • 39. A vision for the surgical management of papillary thyroid carcinoma: extensive lymph node compartmental dissections and selective use of radioiodine.
    Mazzaferri EL
    J Clin Endocrinol Metab; 2009 Apr; 94(4):1086-8. PubMed ID: 19349473
    [No Abstract]   [Full Text] [Related]  

  • 40. The treatment of papillary carcinoma of the thyroid occurring after irradiation.
    Crile G
    Surg Gynecol Obstet; 1980 Jun; 150(6):850-2. PubMed ID: 7376046
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.